3D-MEDNEs: An alternative "in silico" technique for chemical research in toxicology. 2. Quantitative proteome-toxicity relationships (QPTR) based on mass spectrum spiral entropy

Chemical Research in Toxicology

Volumn 21, Issue 3, 2008, Pages 619-632

  Cruz Monteagudo, Maykel ^a,b   González Díaz, Humberto ^c   Borges, Fernanda ^a   Dominguez, Elena Rosa ^b   Cordeiro, M Natália D S ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b CENTRAL UNIVERSITY OF LAS VILLAS   (Cuba)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPUTER MODEL; DNA SEQUENCE; ENTROPY; MASS SPECTROMETRY; PHYSICAL CHEMISTRY; PROTEIN PROTEIN INTERACTION; PROTEOMICS; STOCHASTIC MODEL; TOXICITY TESTING;

ALGORITHMS; ARTIFICIAL INTELLIGENCE; COMPUTER SIMULATION; ENTROPY; GENE LIBRARY; MARKOV CHAINS; MASS SPECTROMETRY; MODELS, STATISTICAL; PROTEOME; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; TOXICOLOGY;

EID: 41849087712     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx700296t     Document Type: Article

References (153)

1. Seifert, M. H. J., Wolf, K., and Vitt, D. (2003) Virtual high-throughput in silico screening. Drug Discovery Today: Biosilico 1, 143-149.
2. van Dalen, E. C., van den Brug, M., Caron, H. N., and Kremer, L. C. (2006) Anthracycline-induced cardiotoxicity: comparison of recommendations for monitoring cardiac function during therapy in paediatric oncology trials. Eur. J. Cancer 42, 3199-3205.
3. Jones, R. L., and Ewer, M. S. (2006) Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs. Exp. Rev. Anticancer Then 6, 1249-1269.
4. Urbanova, D., Urban, L., Carter, A., Maasova, D., and Mladosievicova, B. (2006) Cardiac troponins-biochemical markers of cardiac toxicity after cytostatic therapy. Neoplasma 53, 183-190.
5. Ward, J. B., Jr., and Henderson, R. E. (1996) Identification of needs in biomarker research. Environ. Health Perspect. 104, 895-900.
6. Anderson, N. L., and Anderson, N. G. (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 1, 845-867.
7. Hu, S., Loo, J. A., and Wong, D. T. (2006) Human body fluid proteome analysis. Proteomics 6, 6326-6353.
8. Mehta, A. I., Ross, S., Lowenthal, M. S., Fusaro, V., Fishman, D. A., Petricoin, E. F., 3rd, and Liotta, L. A. (2003) Biomarker amplification by serum carrier protein binding. Dis. Markers 19, 1-10.
9. Liotta, L. A., Ferrari, M., and Petricoin, E. (2003) Clinical proteomics: written in blood. Nature 425, 905-905.
10. Kantor, A. B. (2002) Comprehensive phenotyping and biological marker discovery. Dis. Markers 18, 91-97.
11. McDonald, W. H., and Yates, J. R., 3rd (2002) Shotgun proteomics and biomarker discovery. Dis. Markers 18, 99-105.
12. Petricoin, E. F., Rajapaske, V., Herman, E. H., Arekani, A. M., Ross, S., Johann, D., Knapton, A., Zhang, J., Hitt, B. A., Conrads, T. P., Veenstra, T. D., Liotta, L. A., and Sistare, F. D. (2004) Toxicoproteomics: serum proteomic pattern diagnostics for early detection of drug induced cardiac toxicities and cardioprotection. Toxicol. Pathol. 32, 122-130.
13. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., and Liotta, L. A. (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359, 572-577.
14. Petricoin, E. F., 3rd, Ornstein, D. K., Paweletz, C. P., Ardekani, A., Hackett, P. S., Hitt, B. A., Velassco, A., Trucco, C., Wiegand, L., Wood, K., Simone, C. B., Levine, P. J., Linehan, W. M., Emmert-Buck, M. R., Steinberg, S. M., Kohn, E. C., and Liotta, L. A. (2002) Serum proteomic patterns for detection of prostate cancer. J. Natl. Cancer Inst. 94, 1576-1578.
15. Katritzky, A. R., Fara, D. C., Petrukhin, R. O., Tatham, D. B., Maran, U., Lomaka, A., and Karelson, M. (2002) The present utility and future potential for medicinal chemistry of QSAR/QSPR with whole molecule descriptors. Curr. Top. Med. Chem. 2, 1333-1356.
16. Katritzky, A. R., Petrukhin, R., Tatham, D., Basak, S., Benfenati, E., Karelson, M., and Maran, U. (2001) Interpretation of quantitative structure-property and -activity relationships. J. Chem. Inf. Comput. Sci. 41, 679-685.
17. Katritzky, A. R., Perumal, S., Petrukhin, R., and Kleinpeter, E. (2001) Codessa-based theoretical QSPR model for hydantoin HPLC-RT lipophilicities. J. Chem. Inf. Comput. Sci. 41, 569-574.
18. Katritzky, A. R., and Gordeeva, E. V. (1993) Traditional topological indices vs electronic, geometrical, and combined molecular descriptors in QSAR/QSPR research. J. Chem. Inf. Comput. Sci. 33, 835-857.
19. Estrada, E., and Uriarte, E. (2001) Recent advances on the role of topological indices in drug discovery research. Curr. Med. Chem. 8, 1573-1588.
20. Moridani, M. Y., Siraki, A., Chevaldina, T., Scobie, H., and O'Brien, P. J. (2004) Quantitative structure toxicity relationships for catechols in isolated rat hepatocytes. Chem. Biol. Interact. 147, 297-307.
21. Serra, J. R., Jurs, P. C., and Kaiser, K. L. (2001) Linear regression and computational neural network prediction of tetrahymena acute toxicity for aromatic compounds from molecular structure. Chem. Res. Toxicol. 14, 1535-1545.
22. Gombar, V. K., Enslein, K., and Blake, B. W. (1995) Assessment of developmental toxicity potential of chemicals by quantitative structure-toxicity relationship models. Chemosphere 31, 2499-2510.
23. Siraki, A. G., Chevaldina, T., Moridani, M. Y., and O'Brien, P. J. (2004) Quantitative structure-toxicity relationships by accelerated cytotoxicity mechanism screening. Curr. Opin. Drug Discovery Dev. 7, 118-125.
24. Moudgal, C. J., Venkatapathy, R., Choudhury, H., Bruce, R. M., and Lipscomb, J. C. (2003) Application of QSTRs in the selection of a surrogate toxicity value for a chemical of concern. Environ. Sci. Technol. 37, 5228-5235.
25. Enslein, K., Gombar, V. K., Blake, B. W., Maibach, H. I., Hostynek, J. J., Sigman, C. C., and Bagheri, D. (1997) A quantitative structure-toxicity relationships model for the dermal sensitization guinea pig maximization assay. Food Chem. Toxicol. 35, 1091-1098.
26. Roy, K., and Ghosh, G. (2004) QSTR with extended topochemical atom indices. 2. Fish toxicity of substituted benzenes. J. Chem. Inf. Comput. Sci. 44, 559-567.
27. Basak, S. C., and Mills, D. (2001) Prediction of mutagenicity utilizing a hierarchical QSAR approach. SAR QSAR Environ. Res. 12, 481-496.
28. Saiz-Urra, L., Gonzalez, M. P., and Teijeira, M. (2006) QSAR studies about cytotoxicity of benzophenazines with dual inhibition toward both topoisomerases I and II: 3D-MoRSE descriptors and statistical considerations about variable selection. Bioorg. Med. Chem. 14, 7347-7358.
29. Saiz-Urra, L., Gonzalez, M. P., Fall, Y., and Gomez, G. (2007) Quantitative structure-activity relationship studies of HIV-1 integrase inhibition. 1. GETAWAY descriptors. Eur. J. Med. Chem. 42, 64-70.
30. Saiz-Urra, L., Gonzalez, M. P., Collado, I. G., and Hernandez-Galan, R. (2007) Quantitative structure-activity relationship studies for the prediction of antifungal activity of N-arylbenzenesulfonamides against Botrytis cinerea. J. Mol. Graphics Modell. 25, 680-690.
31. Morales, A. H., Cabrera Perez, M. A., and Gonzalez, M. P. (2006) A radial-distribution-function approach for predicting rodent carcinogenicity. J. Mol. Model. 12, 769-780.
32. Gonzalez, M. P., Teran, C., Teijeira, M., Besada, P., and Gonzalez-Moa, M. J. (2005) BCUT descriptors to predicting affinity toward A3 adenosine receptors. Bioorg. Med. Chem. Lett. 15, 3491-3495.
33. Gonzalez, M. P., Teran, C., and Teijeira, M. (2006) A topological function based on spectral moments for predicting affinity toward A3 adenosine receptors. Bioorg. Med. Chem. Lett. 16, 1291-1296.
34. Gonzalez, M. P., Puente, M., Fall, Y., and Gomez, G. (2006) In silico studies using Radial Distribution Function approach for predicting affinity of 1 alpha,25-dihydroxyvitamin D(3) analogues for Vitamin D receptor. Steroids 71, 510-527.
35. González, M. P., Morales, A. H., and González-Díaz, H. (2004) A TOPS-MODE approach to predict permeability coefficients. Polymer 45, 2073-2079.
36. Gonzalez, M. P., and Moldes del Carmen Teran, M. (2004) A TOPS-MODE approach to predict adenosine kinase inhibition. Bioorg. Med. Chem. Lett. 14, 3077-3079.
37. Gonzalez, M. P., Helguera, A. M., and Collado, I. G. (2006) A topological substructural molecular design to predict soil sorption coefficients for pesticides. Mol. Diversity 10, 109-118.
38. Gonzalez, M. P., Helguera, A. M., and Cabrera, M. A. (2005) Quantitative structure-activity relationship to predict toxicological properties of benzene derivative compounds. Bioorg. Med. Chem. 13, 1775-1781.
39. Fernandez, M., Caballero, J., Helguera, A. M., Castro, E. A., and Gonzalez, M. P. (2005) Quantitative structure-activity relationship to predict differential inhibition of aldose reductase by flavonoid compounds. Bioorg. Med. Chem. 13, 3269-3277.
40. Kier, L. B. (1980) Use of molecular negentropy to encode structure governing biological activity. J. Pharm. Sci. 69, 807-810.
41. Agrawal, V. K., and Khadikar, P. V. (2003) Modelling of carbonic anhydrase inhibitory activity of sulfonamides using molecular negentropy. Bioorg. Med. Chem. Lett. 13, 447-453.
42. Stahura, F. L., Godden, J. W., and Bajorath, J. (2002) Differential Shannon entropy analysis identifies molecular property descriptors that predict aqueous solubility of synthetic compounds with high accuracy in binary QSAR calculations. J. Chem. Inf. Comput. Sci. 42, 550-558.
43. Stahura, F. L., Godden, J. W., Xue, L., and Bajorath, J. (2000) Distinguishing between natural products and synthetic molecules by descriptor Shannon entropy analysis and binary QSAR calculations. J. Chem. Inf. Comput. Sci. 40, 1245-1252.
44. Roy, K., and Saha, A. (2003) Comparative QSPR studies with molecular connectivity, molecular negentropy and TAU indices. Part I: Molecular thermochemical properties of diverse functional acyclic compounds. J. Mol. Model. (Online) 9, 259-270.
45. Agrawal, V. K., Bano, S., and Khadikar, P. V. (2003) QSAR analysis of antibacterial activity of some 4-aminodiphenylsulfone derivatives. Acta Microbiol. Immunol. Hung. 50, 385-393.
46. Agrawal, V. K., Karmarkar, S., and Khadikar, P. V. (2001) QSAR study on binding affinity of PATs (rodenticides) to the [3H]-mepyramine-labelled H1 receptor in rat and guinea pig brain. SAR QSAR Environ. Res. 12, 529-545.
47. Agrawal, V. K., and Khadikar, P. V. (2001) QSAR studies on acylated histamine derivatives. Bioorg. Med. Chem. 9, 2787-2792.
48. Katritzky, A. R., Lomaka, A., Petrukhin, R., Jain, R., Karelson, M., Visser, A. E., and Rogers, R. D. (2002) QSPR correlation of the melting point for pyridinium bromides, potential ionic liquids. J. Chem. Inf. Comput. Sci. 42, 71-74.
49. Strait, B. J., and Dewey, T. G. (1996) The Shannon information entropy of protein sequences. Biophys. J. 71, 148-155.
50. Dima, R. I., and Thirumalai, D. (2004) Proteins associated with diseases show enhanced sequence correlation between charged residues. Bioinformatics 20, 2345-2354.
51. Loewenstern, D., and Yianilos, P. N. (1999) Significantly lower entropy estimates for natural DNA sequences. J. Comput. Biol. 6, 125-142.
52. Manke, T., Demetrius, L., and Vingron, M. (2005) Lethality and entropy of protein interaction networks. Genome Inf. Ser. 16, 159-163.
53. Graham, D. J., and Schacht, D. (2000) Base information content in organic molecular formulae. J. Chem. Inf. Comput. Sci. 40, 942.
54. Graham, D. J. (2002) Information content in organic molecules: structure considerations on the basis of integer statistics. J. Chem. Inf. Comput. Sci. 42, 215.
55. Graham, D. J., Malarkey, C., and Schulmerich, M. V. (2004) Information content in organic molecules: Quantification and statistical structure via Brownian processing. J. Chem. Inf. Comput. Sci. 44, 1601-1611.
56. Graham, D. J., and Schulmerich, M. V. (2004) Information content in organic molecules: reaction pathway analysis via brownian processing. J. Chem. Inf. Comput. Sci. 44, 1612-1622.
57. Graham, D. J. (2005) Information content and organic molecules: Aggregation states and solvent effects. J Chem Inf Model 45, 1223-1236.
58. Graham, D. J. (2007) Information content in organic molecules: Brownian processing at low levels. J Chem Inf Model 47, 376-389.
59. Gan, H. H., Pasquali, S., and Schlick, T. (2003) Exploring the repertoire of RNA secondary motifs using graph theory; implications for RNA design. Nucleic Acids Res. 31, 2926-2943.
60. Chou, K. C. (1990) Applications of graph theory to enzyme kinetics and protein folding kinetics. Steady and non-steady-state systems. Biophys. Chem. 35, 1-24.
61. Mason, O., and Verwoerd, M. (2007) Graph theory and networks in Biology. IET Syst. Biol. 1, 89-119.
62. Harary, F., and Hage, P. (1995) Eccentricity and centrality in networks. Social Networks 17, 57-63.
63. Freund, J. A., and Poschel, T. (2000) Stochastic Processes in Physics, Chemistry, and Biology; Lecture Notes in Physics 557; Springer-Verlag, Berlin, Germany.
64. González-Díaz, H., Uriarte, E., and Ramos de Armas, R. (2005) Predicting stability of Arc repressor mutants with protein stochastic moments. Bioorg. Med. Chem. 13, 323-331.
65. Gonzalez-Diaz, H., Molina, R., and Uriarte, E. (2005) Recognition of stable protein mutants with 3D stochastic average electrostatic potentials. FEBS Lett. 579, 4297-4301.
66. Aguero-Chapin, G., Gonzalez-Diaz, H., Molina, R., Varona-Santos, J., Uriarte, E., and Gonzalez-Diaz, Y. (2006) Novel 2D maps and coupling numbers for protein sequences. The first QSAR study of polygalacturonases; isolation and prediction of a novel sequence from Psidium guajava L. FEBS Lett. 580, 723-730.
67. Santana, L., Uriarte, E., Gonzalez-Diaz, H., Zagotto, G., Soto-Otero, R., and Mendez-Alvarez, E. (2006) A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins. J. Med. Chem. 49, 1149-1156.
68. González-Díaz, H., Vilar, S., Santana, L., and Uriarte, E. (2007) Medicinal chemistry and bioinformatics - Current trends in drugs discovery with networks topological indices. Curr. Top. Med. Chem. 7, 1025-1039.
69. González-Díaz, H., and Uriarte, E. (2005) Biopolymer stochastic moments. I. Modeling human rhinovirus cellular recognition with protein surface electrostatic moments. Biopolymers 77, 296-303.
70. González-Díaz, H., Molina, R., and Uriarte, E. (2004) Markov entropy backbone electrostatic descriptors for predicting proteins biological activity. Bioorg. Med. Chem. Lett. 14, 4691-4695.
71. Ramos de Armas, R., González-Díaz, H., Molina, R., Perez Gonzalez, M., and Uriarte, E. (2004) Stochastic-based descriptors studying peptides biological properties: modeling the bitter tasting threshold of dipeptides. Bioorg. Med. Chem. 12, 4815-4822.
72. González-Díaz, H., de Armas, R. R., and Molina, R. (2003) Markovian negentropies in bioinformatics. 1. A picture of footprints after the interaction of the HIV-1 Psi-RNA packaging region with drugs. Bioinformatics 19, 2079-2087.
73. González-Díaz, H., Vina, D., Santana, L., de Clercq, E., and Uriarte, E. (2006) Stochastic entropy QSAR for the in silico discovery of anticancer compounds: Prediction, synthesis, and in vitro assay of new purine carbanucleosides. Bioorg. Med. Chem. 14, 1095-1107.
74. Cruz-Monteagudo, M., and González-Díaz, H. (2005) Unified drug-target interaction thermodynamic Markov model using stochastic entropies to predict multiple drugs side effects. Eur. J. Med. Chem. 40, 1030-1041.
75. González-Díaz, H., Aguero, G., Cabrera, M. A., Molina, R., Santana, L., Uriarte, E., Delogu, G., and Castanedo, N. (2005) Unified Markov thermodynamics based on stochastic forms to classify drugs considering molecular structure, partition system, and biological species: Distribution of the antimicrobial G1 on rat tissues. Bioorg. Med. Chem. Lett. 15, 551-557.
76. González-Díaz, H., Saíz-Urra, L., Molina, R., and Uriarte, E. (2005) Stochastic molecular descriptors for polymers. 2. Spherical truncation of electrostatic interactions on entropy based polymers 3D-QSAR. Polymer 46, 2791-2798.
77. Gonzalez-Diaz, H., Perez-Castillo, Y., Podda, G., and Uriarte, E. (2007) Computational chemistry comparison of stable/nonstable protein mutants classification models based on 3D and topological indices. J. Comput. Chem. 28, 1990-1995.
78. Gonzalez-Diaz, H., Saiz-Urra, L., Molina, R., Santana, L., and Uriarte, E. (2007) A model for the recognition of protein kinases based on the entropy of 3D van der Waals interactions. J. Proteome Res. 6, 904-908.
79. González-Díaz, H., Olazabal, E., Castanedo, N., Sanchez, I. H., Morales, A., Serrano, H. S., Gonzalez, J., and de Armas, R. R. (2002) Markovian chemicals "in silico" design (MARCH-INSIDE), a promising approach for computer aided molecular design II: Experimental and theoretical assessment of a novel method for virtual screening of fasciolicides. J. Mol. Model. 8, 237-245.
80. González-Díaz, H., Gia, O., Uriarte, E., Hernadez, I., Ramos, R., Chaviano, M., Seijo, S., Castillo, J. A., Morales, L., Santana, L., Akpaloo, D., Molina, E., Cruz, M., Torres, L. A., and Cabrera, M. A. (2003) Markovian chemicals "in silico" design (MARCH-INSIDE), a promising approach for computer-aided molecular design I: Discovery of anticancer compounds. J. Mol. Model. 9, 395-407.
81. González-Díaz, H., Torres-Gomez, L. A., Guevara, Y., Almeida, M. S., Molina, R., Castanedo, N., Santana, L., and Uriarte, E. (2005) Markovian chemicals "in silico" design (MARCH-INSIDE), a promising approach for computer-aided molecular design III: 2.5D indices for the discovery of antibacterials. J. Mol. Model. 11, 116-123.
82. González-Díaz, H., Agüero-Chapin, G., Varona, J., Molina, R., Delogu, G., Santana, L., Uriarte, E., and Gianni, P. (2007) 2D-RNA-coupling numbers: A new computational chemistry approach to link secondary structuretopology with biological function. J. Comput. Chem. 28, 1049-1056.
83. González-Díaz, H., Bastida, I., Castanedo, N., Nasco, O., Olazabal, E., Morales, A., Serrano, H. S., and de Armas, R. R. (2004) Simple stochastic fingerprints towards mathematical modelling in biology and medicine. 1. The treatment of coccidiosis. Bull. Math. Biol. 66, 1285-1311.
84. Cruz-Monteagudo, M., González-Díaz, H., and Uriarte, E. (2006) Simple stochastic fingerprints towards mathematical modeling in biology and medicine 2. Unifying Markov model for drugs side effects. Bull. Math. Biol. 68, 1527-1554.
85. González-Díaz, H., Cruz-Monteagudo, M., Vina, D., Santana, L., Uriarte, E., and De Clercq, E. (2005) QSAR for anti-RNA-virus activity, synthesis, and assay of anti-RSV carbonucleosides given a unified representation of spectral moments, quadratic, and topologic indices. Bioorg. Med. Chem. Lett. 15, 1651-1657.
86. González-Díaz, H., Aguero-Chapin, G., Varona-Santos, J., Molina, R., de la Riva, G., and Uriarte, E. (2005) 2D RNA-QSAR: Assigning ACC oxidase family membership with stochastic molecular descriptors; isolation and prediction of a sequence from Psidium guajava L. Bioorg. Med. Chem. Lett. 15, 2932-2937.
87. Gonzalez-Diaz, H., Tenorio, E., Castanedo, N., Santana, L., and Uriarte, E. (2005) 3D QSAR Markov model for drug-induced eosinophilia-theoretical prediction and preliminary experimental assay of the antimicrobial drug G1. Bioorg. Med. Chem. 13, 1523-1530.
88. González-Díaz, H., Olazábal, E., Santana, L., Uriarte, E., and Castañedo, N. (2007) QSAR study of anticoccidial activity for diverse chemical compounds: prediction and experimental assay of trans-2-(2-nitrovinyl)furan. Bioorg. Med. Chem. 15, 962-968.
89. González-Díaz, H., Cruz-Monteagudo, M., Molina, R., Tenorio, E., and Uriarte, E. (2005) Predicting multiple drugs side effects with a general drug-target interaction thermodynamic Markov model. Bioorg. Med. Chem. 13, 1119-1129.
90. Gia, O., Marciani Magno, S., González-Díaz, H., Quezada, E., Santana, L., Uriarte, E., and Dalla Via, L. (2005) Design, synthesis and photobiological properties of 3,4-cyclopentenepsoralens. Bioorg. Med. Chem. 13, 809-817.
91. Bartels, C. (1990) Fast algorithm for peptide sequencing by mass spectroscopy. Biomed. Environ. Mass Spectrom. 19, 363-368.
92. Bandeira, N. (2007) Spectral networks: A new approach to de novo discovery of protein sequences and posttranslational modifications. Biotechniques 42, 691.
93. Bandeira, N., Clauser, K. R., and Pevzner, P. A. (2007) Shotgun protein sequencing: Assembly of peptide tandem mass spectra from mixtures of modified proteins. Mol. Cell. Proteomics 6, 1123-1134.
94. Bandeira, N., Tsur, D., Frank, A., and Pevzner, P. A. (2007) Protein identification by spectral networks analysis. Proc. Natl. Acad. Sci. U.S.A. 104, 6140-6145.
95. Bandeira, N., Tang, H., Bafna, V., and Pevzner, P. (2004) Shotgun protein sequencing by tandem mass spectra assembly. Anal. Chem. 76, 7221-7233.
96. González-Díaz, H., Marrero, Y., Hernandez, I., Bastida, I., Tenorio, E., Nasco, O., Uriarte, E., Castanedo, N., Cabrera, M. A., Aguila, E., Marrero, O., Morales, A., and Perez, M. (2003) 3D-MEDNEs: An alternative "in silico" technique for chemical research in toxicology. 1. Prediction of chemically induced agranulocytosis. Chem. Res. Toxicol. 16, 1318-1327.
97. Randic, M., Lers, N., Plavsic, D., Basak, S. C., and Balaban, A. T. (2005) Four-color map representation of DNA or RNA sequences and their numerical characterization. Chem. Phys. Lett. 407, 205-208.
98. Conrads, T. P., Zhou, M., Petricoin, E. F., Liotta, L. A., and Veenstra, T. D. (2003) Cancer diagnosis using proteomic patterns. Exp. Rev. Mol. Diagn. 3, 411-420.
99. Lambertenghi-Deliliers, G., Zanon, P. L., Pozzoli, E. F., and Bellini, O. (1976) Myocardial injury induced by a single dose of adriamycin: An electron microscopic study. Tumori 62, 517-528.
100. Zhang, J., Herman, E. H., and Ferrans, V. J. (1993) Dendritic cells in the hearts of spontaneously hypertensive rats treated with doxorubicin with or without ICRF-187. Am. J. Pathol. 142, 1916-1926.
101. Herman, E. H., Zhang, J., Rifai, N., Lipshultz, S. E., Hasinoff, B. B., Chadwick, D. P., Knapton, A., Chai, J., and Ferrans, V. J. (2001) The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitox-antrone-induced cardiotoxicity. Cancer Chemother. Pharmacol. 48, 297-304.
102. Zhang, J., Herman, E. H., Knapton, A., Chadwick, D. P., Whitehurst, V. E., Koerner, J. E., Papoian, T., Ferrans, V. J., and Sistare, F. D. (2002) SK&F 95654-induced acute cardiovascular toxicity in Sprague-Dawley rats - histopathologic, electron microscopic, and immunohistochemical studies. Toxicol. Pathol. 30, 28-40.
103. Van Waterbeemd, H. (1995) Discriminant analysis for activity prediction, In Chemometric Methods in Molecular Design, (Van Waterbeemd, H., Ed.) pp 265-282, Wiley-VCH, New York.
104. (2001)ATISTICA, Statsoft Inc.
105. Kowalski, R. B., and Wold, S. (1982) Pattern recognition in chemistry, In Handbook of Statistics, (Krishnaiah, P. R., and Kanal, L. N., Eds.) pp 673-697, North Holland Publishing Company, Amsterdam.
106. Van Waterbeemd, H. (1995) Chemometric Methods in Molecular Design, Vol. 2, Wiley-VCH, New York.
107. Cruz-Monteagudo, M., Gonzalez-Diaz, H., Aguero-Chapin, G., Santana, L., Borges, F., Dominguez, E. R., Podda, G., and Uriarte, E. (2007) Computational chemistry development of a unified free energy Markov model for the distribution of 1300 chemicals to 38 different environmental or biological systems. J. Comput. Chem. 28, 1909-1923.
108. Stewart, J. and Gill, L. (1998) Econometrics, 2nd ed., Prentice Hall, London.
109. Kutner, M. H., Nachtsheim, C. J., Neter, J. and Li, W. (2005) Standardized multiple regression model, Applied Linear Statistical Models pp 271-277, McGraw Hill, New York.
110. González-Díaz, H., Molina-Ruiz, R. and Hernandez, I. (2007)MARCH-INSIDE, version 3.0 (MARkov CHains INvariants for SImulation and DEsign), MARCH-INSIDE, version 3.0 (MARkov CHains INvariants for Simulation and DEsign). Main author information requesting contact e-mail: gonzalezdiazh@yahoo. es.
111. Saiz-Urra, L., González-Díaz, H., and Uriarte, E. (2005) Proteins Markovian 3D-QSAR with spherically-truncated average electrostatic potentials. Bioorg. Med. Chem. 13, 3641-3647.
112. González-Díaz, H., and Uriarte, E. (2005) Proteins QSAR with Markov average electrostatic potentials. Bioorg. Med. Chem. Lett. 15, 5088-5094.
113. Gonzalez-Diaz, H., Sanchez-Gonzalez, A., and Gonzalez-Diaz, Y. (2006) 3D-QSAR study for DNA cleavage proteins with a potential anti-tumor ATCUN-like motif. J. Inorg. Biochem. 100, 1290-1297.
114. Gonzalez-Diaz, H., Saiz-Urra, L., Molina, R., Gonzalez-Diaz, Y., and Sanchez-Gonzalez, A. (2007) Computational chemistry approach to protein kinase recognition using 3D stochastic van der Waals spectral moments. J. Comput. Chem. 28, 1042-1048.
115. Ramos de Armas, R., González-Díaz, H., Molina, R., and Uriarte, E. (2004) Markovian backbone negentropies: Molecular descriptors for protein research. I. Predicting protein stability in Arc repressor mutants. Proteins 56, 715-723.
116. Radestock, S., Bohm, M., and Gohlke, H. (2005) Improving binding mode predictions by docking into protein-specifically adapted potential fields. J. Med. Chem. 48, 5466-5479.
117. Randic, M. (2004) Graphical representations of DNA as 2-D map. Chem. Phys. Lett. 386, 468-471.
118. Gonzalez-Diaz, H., Perez-Bello, A., Uriarte, E., and Gonzalez-Diaz, Y. (2006) QSAR study for mycobacterial promoters with low sequence homology. Bioorg. Med. Chem. Lett. 16, 547-553.
119. González-Díaz, H., Pérez-Bello, A., Cruz-Monteagudo, M., González-Díaz, Y., Santana, L., and Uriarte, E. (2007) Chemometrics for QSAR with low sequence homology: Mycobacterial promoter sequences recognition with 2D-RNA entropies. Chemom. Intell. Lab. Syst. 85, 20-26.
120. Gonzalez-Diaz, H., Vina, D., Santana, L., de Clercq, E., and Uriarte, E. (2006) Stochastic entropy QSAR for the in silico discovery of anticancer compounds: Prediction, synthesis, and in vitro assay of new purine carbanucleosides. Bioorg. Med. Chem. 14, 1095-1107.
121. González-Díaz, H., Pérez-Bello, A., and Uriarte, E. (2005) Stochastic molecular descriptors for polymers. 3. Markov electrostatic moments as polymer 2D-folding descriptors: RNA-QSAR for mycobacterial promoters. Polymer 46, 6461-6473.
122. Gromiha, M. M., Oobatake, M., Kono, H., Uedaira, H., and Sarai, A. (1999) Role of structural and sequence information in the prediction of protein stability changes: Comparison between buried and partially buried mutations. Protein Eng. 12, 549-555.
123. Zweig, M. H. (1994) Apolipoproteins and lipids in coronary artery disease. Analysis of diagnostic accuracy using receiver operating characteristic plots and areas. Arch. Pathol. Lab. Med. 118, 141-144.
124. Zweig, M. H., Broste, S. K., and Reinhart, R. A. (1992) ROC curve analysis: An example showing the relationships among serum lipid and apolipoprotein concentrations in identifying patients with coronary artery disease. Clin. Chem. 38, 1425-1428.
125. Morales, A. H., Perez, M. A., Combes, R. D., and Gonzalez, M. P. (2006) Quantitative structure activity relationship for the computational prediction of nitrocompounds carcinogenicity. Toxicology 220, 51-62.
126. Kutner, M. H., Nachtsheim, C. J., Neter, J. and Li, W. (2005) Multicollinearity and its effects, In Applied Linear Statistical Models, pp 278-289, McGraw Hill, New York.
127. Prusis, P., Lundstedt, T., and Wikberg, J. E. (2002) Proteochemometrics analysis of MSH peptide binding to melanocortin receptors. Protein Eng. 15, 305-311.
128. Devillers, J., Chezeau, A., and Thybaud, E. (2002) PLS-QSAR of the adult and developmental toxicity of chemicals to Hydra attenuata. SAR QSAR Environ. Res. 13, 705-712.
129. Taraviras, S. L., Ivanciuc, O., and Cabrol-Bass, D. (2000) Identification of groupings of graph theoretical molecular descriptors using a hybrid cluster analysis approach. J. Chem. Inf. Comput. Sci. 40, 1128-1146.
130. Mei, H., Liao, Z. H., Zhou, Y., and Li, S. Z. (2005) A new set of amino acid descriptors and its application in peptide QSARs. Biopolymers 80, 775-786.
131. Jacobs, M. N. (2004) In silico tools to aid risk assessment of endocrine disrupting chemicals. Toxicology 205, 43-53.
132. Randi∫, M. (1991) Orthogonal molecular descriptors. New J. Chem. 15, 517-525.
133. Randi∫, M. (1991) Resolution of ambiguities in structure-property studies by use of orthogonal descriptors. J. Chem. Inf. Comput. Sci. 31, 311-370.
134. Randi∫, M. (1993) Fitting of non linear regressions by orthogonalized power series. J. Comput. Chem. 14, 363-370.
135. (2002) Waikato Environment for Knowledge Analysis (WEKA), University of Waikato, New Zealand.
136. Witten, I. H. and Frank, E. (2005) Data Mining: Practical Machine Learning Tools and Techniques, 2nd ed, San Francisco, CA.
137. Frank, E., Hall, M., Trigg, L., Holmes, G., and Witten, I. H. (2004) Data mining in bioinformatics using Weka. Bioinformatics 20, 2479-2481.
138. Nascimento, D. G., Rates, B., Santos, D. M., Verano-Braga, T., Barbosa-Silva, A., Dutra, A. A., Biondi, I., Martin-Eauclaire, M. F., De Lima, M. E., and Pimenta, A. M. (2006) Moving pieces in a taxonomic puzzle: Venom 2D-LC/MS and data clustering analyses to infer phylogenetic relationships in some scorpions from the Buthidae family (Scorpiones). Toxicon 47, 628-639.
139. Pillai, S., Good, B., Richman, D., and Corbeil, J. (2003) A new perspective on V3 phenotype prediction. AIDS Res. Hum. Retroviruses 19, 145-149.
140. Witten, I. H. and Frank, E. (2000) Data Mining: Practical Machine Learning Tools and Techniques with Java Implementations, pp265-320Morgan Kaufmann, San Francisco, CA.
141. Liao, B. (2005) A 2D graphical representation of DNA sequence. Chem. Phys. Lett. 401, 196-199.
142. Liao, B., Tan, M., and Ding, K. (2005) Application of 2-D graphical representation of DNA sequence. Chem. Phys. Lett. 414, 296-300.
143. Liao, B., Tan, M., and Ding, K. (2005) A 4D representation of DNA sequences and its application. Chem. Phys. Lett. 402, 380-383.
144. Randi∫, M., Vracko, M., Zupan, J., and Novic, M. (2003) Compact 2-D graphical representation of DNA. Chem. Phys. Lett. 373, 558-562.
145. Randi∫, M., Lers, N., Plavsi∫, D., Basak, S., and Balaban, A. T. (2005) Four-color map representation of DNA or RNA sequences and their numerical characterization. Chem. Phys. Lett. 407, 205-208.
146. Liu, Y., Guo, X., Xu, J., Pan, L., and Wang, S. (2002) Some notes on 2-D graphical representation of DNA sequence. J. Chem. Inf. Comput. Sci. 42, 529-533.
147. Randi∫, M. (2000) Condensed representation of DNA primary sequences. J. Chem. Inf. Comput. Sci. 40, 50-56.
148. Randi∫, M., and Balaban, A. T. (2003) On a four-dimensional representation of DNA primary sequences. J. Chem. Inf. Comput. Sci. 43, 532-539.
149. Randi∫, M., Vračko, M., Nandy, A., and Basak, S. C. (2000) On 3-D graphical representation of dna primary sequences and their numerical characterization. J. Chem. Inf. Comput. Sci. 40, 1235-1244.
150. Zupan, J., and Randi∫, M. (2005) Algorithm for coding DNA sequences into "spectrum-like" and "zigzag" representations. J. Chem. Inf. Model. 45, 309-313.
151. Liao, B., and Wang, T. M. (2004) New 2D graphical representation of DNA sequences. J. Comput. Chem. 25, 1364-1368.
152. Randi∫, M. (2004) 2-D graphical representation of proteins based on virtual genetic code. SAR QSAR Environ. Res. 15, 147-157.
153. Randi∫, M., and Zupan, J. (2004) Highly compact 2D graphical representation of DNA sequences. SAR QSAR Environ. Res. 15, 191-205.